Our Identity.
Your Trust.

At NephroPlus clarity & trust guide everything we do.

We are Nephrocare Health Services Limited, operating under the brand name NephroPlus, a leading dialysis care network serving thousands of dialysis patients every month across India and select international markets.

Brand Identity & Affiliation Disclaimer:

Nephrocare Health Services Limited operates independently under its own brand identity “NephroPlus” and is not affiliated, linked, or connected with any other organization, clinic, hospital, or service provider that may use the names “Nephrocare,” “Nephro,” “NephroCare,” or any similar spelling or variation in India or abroad.

About NephroPlus

  • Registered Name: Nephrocare Health Services Limited
  • Brand Name: NephroPlus
  • Founded: 2010
  • Headquarters: Hyderabad, India
  • Global Network: 500+ dialysis centres across 5 countries
  • DRHP Filed: July 2025

NephroPlus continues to build Asia’s most trusted kidney care network, focused on quality dialysis outcomes, innovation and patient well-being.

What Makes NephroPlus Different

Scale and Reach

With 500+ state-of-the-art centres across India and international markets, NephroPlus serves over 33,000 dialysis patients every month.

Clinical Excellence

Our care model is built on consistent SOPs, trained professionals and rigorous clinical governance ensuring safe, quality dialysis every time.

Technology-Driven Care

From digital patient portals to advanced home dialysis setups, we leverage technology to make dialysis care accessible, efficient and patient-centric.

Purpose-Driven Philosophy

At NephroPlus, we help our guests (patients) thrive, not just survive. This reflects our unwavering focus on quality of life.

Brand Identity & Affiliation Disclaimer

We understand there may be confusion due to other companies using similar names, such as NephroCare or Nephro Care. To avoid confusion, we request patients, partners, vendors, and the general public to verify official association before entering into any communication or transaction.

All our communications, announcements and investor information are shared exclusively through the following official channels:

Official Website

Investor Relations

Investor Queries

Media Queries

Official Social Channels

If you come across any communication or listing under the name “NephroCare” or “NephroCare,” please note that it is not associated with NephroPlus. We remain committed to transparency, patient trust, and the highest standards of care.

Investor Communication & Verification

NephroPlus (Nephrocare Health Services Limited) filed its Draft Red Herring Prospectus (DRHP) with SEBI in July 2025 as part of its proposed public offering.

All verified investor information, financial updates and regulatory disclosures will be available only on our official investor relations page and through SEBI-authorised platforms.

Access Official Investor Documents →

Frequently Asked Questions

Quick answers to the questions you may have.

No. NephroPlus is an independent company with no connection to similarly named providers.

NephroPlus (Nephrocare Health Services Limited) filed its DRHP in July 2025. No other similarly named company is part of this process.

Healthcare terms like “nephro” are commonly used, which leads to name overlap. However, the entities are unrelated.

Always look for:

NephroPlus Logo
• Website: www.nephroplus.com
• Official filings under: Nephrocare Health Services Ltd.

Official filings under “Nephrocare Health Services Ltd.” only. Please confirm using official sources before proceeding.

All official IPO-related updates, financial disclosures, and regulatory announcements are available only on:

• The NephroPlus Investor Relations page: www.nephroplus.com/investors
• The SEBI and Stock Exchange (NSE/BSE) websites under the company name Nephrocare Health Services Limited.

We do not release IPO or investment information through social media, personal emails, or third-party platforms.

Check that:

• The document carries the NephroPlus logo and registered company name (Nephrocare Health Services Limited).
• The source domain is @nephroplus.com.
• The content matches information available on our official investor relations page or SEBI-authorised filings.

If in doubt, email ir@nephroplus.com for verification.

The official DRHP filed with SEBI in July 2025 can be accessed through:
• The SEBI website (www.sebi.gov.in)
• Stock exchange websites (NSE / BSE)
• NephroPlus Investor Relations portal www.nephroplus.com/investors
• NephroPlus Investor Relations portal

Any DRHP or prospectus shared outside these sources should be treated as unauthorised.

Please exercise caution. NephroPlus (Nephrocare Health Services Ltd.) has not authorised any third party, intermediary, or individual to solicit investments or collect funds on its behalf.

All investment opportunities or share allocations will be made only through SEBI-authorised intermediaries and exchanges.

Look for:
• Official website: www.nephroplus.com
• Verified social handles: LinkedIn, X (Twitter), YouTube, Instagram, Facebook, and WhatsApp Business with the verified NephroPlus logo.
• Corporate filings under: Nephrocare Health Services Limited.

Any page or communication without these identifiers is not linked to NephroPlus.

No. All verified investor updates will be released through:

• Press releases
• The official NephroPlus website
• SEBI and Stock Exchange filings

We do not share IPO or investor-related details through WhatsApp forwards, private messages, or unverified groups.

For investor queries, media clarification, or patient information, contact:

Email:contactus@nephroplus.com
Phone:1800 120 001 001

Visit Investor RelationsDownload DRHP SummaryContact Investor Relations

NephroPlus remains committed to providing transparent communication and world-class kidney care for our guests (patients), partners, and investors.

Appointment Float Right
Book an
Appointment
Whatsapp Float
Whatsapp
Appointment Float
Book an Appointment
Call Float
Call